181 related articles for article (PubMed ID: 30082544)
21. Epidemiology of pediatric hematological malignancies in Kazakhstan: Data from Unified National Electronic Healthcare System 2014-2021.
Mussina K; Kuanova B; Syssoyev D; Gaipov A; Poddighe D; Shaikhyzada K; Aimyshev T; Galiyeva D
Eur J Pediatr; 2024 Apr; 183(4):1683-1691. PubMed ID: 38214809
[TBL] [Abstract][Full Text] [Related]
22. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
[TBL] [Abstract][Full Text] [Related]
23. Spectrum of AIDS defining & non-AIDS defining malignancies in north India.
Sachdeva RK; Sharma A; Singh S; Varma S
Indian J Med Res; 2016 May; 143(Supplement):S129-S135. PubMed ID: 27748287
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in the understanding and treatment of pediatric leukemias.
Maloney KW; Giller R; Hunger SP
Adv Pediatr; 2012; 59(1):329-58. PubMed ID: 22789585
[No Abstract] [Full Text] [Related]
25. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Pulte D; Gondos A; Brenner H
J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
[TBL] [Abstract][Full Text] [Related]
26. [Multifocal osteonecrosis in children and adolescents after polychemotherapy].
Raab P; Kühl J; Krauspe R
Z Orthop Ihre Grenzgeb; 1997; 135(5):444-50. PubMed ID: 9446438
[TBL] [Abstract][Full Text] [Related]
27. A morphological pattern of 234 cases of leukemias.
Hassan K; Ikram N; Shah SH
J Pak Med Assoc; 1994 Jun; 44(6):145-8. PubMed ID: 8089909
[TBL] [Abstract][Full Text] [Related]
28. P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia.
Carulli G; Petrini M; Marini A; Vaglini F; Caracciolo F; Grassi B
Haematologica; 1990; 75(6):516-21. PubMed ID: 1982999
[TBL] [Abstract][Full Text] [Related]
29. Pediatric cancer-associated thrombosis: Analysis from a tertiary care cancer center in India.
Dhariwal N; Gollamudi VRM; Sangeetha KP; Parambil BC; Moulik NR; Dhamne C; Prasad M; Vora T; Chinnaswamy G; Kembhavi S; Subramanian PG; Gujral S; Banavali SD; Narula G
Pediatr Blood Cancer; 2023 Feb; 70(2):e30096. PubMed ID: 36401555
[TBL] [Abstract][Full Text] [Related]
30. Progress and Prospects in Pediatric Leukemia.
Madhusoodhan PP; Carroll WL; Bhatla T
Curr Probl Pediatr Adolesc Health Care; 2016 Jul; 46(7):229-241. PubMed ID: 27283082
[TBL] [Abstract][Full Text] [Related]
31. [Pediatric oncology: results and future therapeutic perspectives].
Paolucci G; Vecchi V; Burnelli R; Facchini E; Civino A; Pericoli R; Borghetti A
Minerva Pediatr; 1993 Sep; 45(9):325-39. PubMed ID: 8302228
[No Abstract] [Full Text] [Related]
32. Metastatic lesions to the skin in children and adolescents.
Pesce K; Hoss DM; Berke A; Grant-Kels JM
Adv Dermatol; 1997; 12():237-74; discussion 275. PubMed ID: 8973743
[No Abstract] [Full Text] [Related]
33. Impact of Social Disparities on 5-Year Survival Rates in Pediatric Hematologic Malignancies.
Chalfant V; Riveros C; Bechtel A; Bradfield SM; Stec AA
J Pediatr Hematol Oncol; 2024 Jan; 46(1):33-38. PubMed ID: 37910818
[TBL] [Abstract][Full Text] [Related]
34. Childhood hematopoietic malignancies and parental use of tobacco and alcohol: the ESCALE study (SFCE).
Rudant J; Menegaux F; Leverger G; Baruchel A; Lambilliotte A; Bertrand Y; Patte C; Pacquement H; Vérité C; Robert A; Michel G; Margueritte G; Gandemer V; Hémon D; Clavel J
Cancer Causes Control; 2008 Dec; 19(10):1277-90. PubMed ID: 18618277
[TBL] [Abstract][Full Text] [Related]
35. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005.
Pulte D; Gondos A; Brenner H
Cancer; 2009 Nov; 115(21):4973-9. PubMed ID: 19705347
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of patients with Down syndrome and acute leukemia: A retrospective observational study.
Schmidt MP; Colita A; Ivanov AV; Coriu D; Miron IC
Medicine (Baltimore); 2021 Oct; 100(40):e27459. PubMed ID: 34622870
[TBL] [Abstract][Full Text] [Related]
37. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
[TBL] [Abstract][Full Text] [Related]
38. [Lymphatic neoplasias in young patients].
Borchmann P; Gökbuget N; Wulf G; Trümper L
Onkologie; 2011; 34 Suppl 5():6-11. PubMed ID: 21921661
[No Abstract] [Full Text] [Related]
39. Pediatric acute leukemia: the effect of prognostic factors on clinical outcomes at Phramongkutklao Hospital, Bangkok, Thailand.
Rujkijyanont P; Kaewinsang S; Monsereenusorn C; Traivaree C
J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S188-95. PubMed ID: 25518193
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area.
Howard SC; Pedrosa M; Lins M; Pedrosa A; Pui CH; Ribeiro RC; Pedrosa F
JAMA; 2004 May; 291(20):2471-5. PubMed ID: 15161898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
